News – University of Pittsburgh Center for Preclinical Studies

Newscpcsus3r0204882022-07-26T14:00:42+00:00

Company Inks Robotic Surgery Partnership with Pitt-UPMC Venture
Company Inks Robotic Surgery Partnership with Pitt-UPMC Venture

Company Inks Robotic Surgery Partnership with Pitt-UPMC Venture

A Massachusetts company is pa ...

Shunt to Treat Fetal Hydrocephalus In-Utero
Shunt to Treat Fetal Hydrocephalus In-Utero

Shunt to Treat Fetal Hydrocephalus In-Utero

"In 2014 the 25 Club donated ...

McGowan Institute Quality Management Specialists Assist Pitt’s Center for Vaccine Research and Others
McGowan Institute Quality Management Specialists Assist Pitt’s Center for Vaccine Research and Others

McGowan Institute Quality Management Specialists Assist Pitt’s Center for Vaccine Research and Others

McGowan Institute for Regener ...

Pitt-McGowan Institute Center for Preclinical Studies Supports Total Artificial Heart Study
Pitt-McGowan Institute Center for Preclinical Studies Supports Total Artificial Heart Study

Pitt-McGowan Institute Center for Preclinical Studies Supports Total Artificial Heart Study

Carmat, a developer of an art ...

Carmat – Update on the US Early Feasibility Study
Carmat – Update on the US Early Feasibility Study

Carmat – Update on the US Early Feasibility Study

Update on the US Early Feasib ...

“Since the start of the collaboration with MIRM CPCS we felt at home and their team as an extension of our staff. We found a passionate group of people with a lot of experience in the field whose sole goal is to make your program successful. Moreover, MIRM’s facility is adapted to our needs. The CPCS has a dedicated and experienced team with a facility, professional OR and lecture facilities that allows privacy and focus for you and your customers. CARMAT selected the CPCS as the sole US Training Center supporting the qualification of surgeons from all US Clinical Trial sites. Initiated in 2019, Carmat has completed fifteen training events; we look forward to continuing this relationship.”

Francesco Arecchi, Director of Global Market Development for Carmat

“Founded in 1998, XVIVO (Gothenburg, Sweden) is the only medical technology company dedicated to extending the life of all major organs – so transplant teams around the world can save more lives. XVIVO is the forerunner in life-extending technologies for organs. We lead the way by following the science. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO provides clinically optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation…Read More

Arjan Van Der Plaats, PhD, Research and Development Director for XVIVO

Latest News

Company Inks Robotic Surgery Partnership with Pitt-UPMC Venture

Shunt to Treat Fetal Hydrocephalus In-Utero

McGowan Institute Quality Management Specialists Assist Pitt’s Center for Vaccine Research and Others